Literature DB >> 4159267

Interaction between poliovirus and immunoglobulins. II. Basic aspects of virus-antibody interaction.

L Phillipson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4159267     DOI: 10.1016/0042-6822(66)90304-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  9 in total

1.  Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization.

Authors:  M M Rweyemamu; J C Booth; T W Pay
Journal:  J Hyg (Lond)       Date:  1977-02

2.  Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.

Authors:  W K Ashe; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

3.  Neutralization of infectious ME (Maus-Elberfeld) virus-antibody complexes by anti-gamma-globulin antibody.

Authors:  J Cihak
Journal:  Med Microbiol Immunol       Date:  1973-09-26       Impact factor: 3.402

4.  Determination of equine serum inhibitors for poliovirus by the gel-adsorption technique.

Authors:  R Thomssen; G Koehne-Barleben; A Schober
Journal:  Arch Gesamte Virusforsch       Date:  1966

5.  The protective effect of different immunoglobulins against herpetic encephalitis and skin infection in guinea pigs.

Authors:  T Tokumaru
Journal:  Arch Gesamte Virusforsch       Date:  1967

6.  Studies on influenza virus hemagglutination inhibition by anti-host serum.

Authors:  M Majer
Journal:  Arch Gesamte Virusforsch       Date:  1973

7.  Distribution of free and antibody-bound peptide hormones in two-phase aqueous polymer systems.

Authors:  B Desbuquois; G D Aurbach
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

8.  Studies on the non-neutralizable fraction of vaccinia virus.

Authors:  M Majer; F Link
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

Review 9.  The antiviral activity of antibodies in vitro and in vivo.

Authors:  P W Parren; D R Burton
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.